EUVIMEDObjevte EUVIMED
Crossref

The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis

Chen Zong iD, Shiyu Wu, Longyang Zhu, Yiran Chen, Xinxin Zhang, Chao Sun, Xin Lu, Guochun Wang, Qinglin Peng iD

Respirology · 2025-12 · 30 (12) · 1153-1164

DOI: 10.1111/resp.70106 ↗

At a glance

Journal article in Respirology, published online on 2025-08-18. Written by Chen Zong and 8 co-authors. Institution: Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. Major MEDLINE topics: Dermatomyositis, Interferon-Induced Helicase, IFIH1. Cited 8 times so far (Crossref); 47 references. Funded by: Elite Medical Professionals project of China-Japan Friendship Hospital, National High Level Hospital Clinical Research Funding, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Objective Anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis (MDA5 + DM) exhibits the worst prognosis among all subtypes of idiopathic inflammatory myopathies, with substantial heterogeneity in patient outcomes. This study aimed to investigate prognostic factors for MDA5 + DM and develop a scoring system to determine mortality risk.

Methods

This retrospective study included 621 patients with MDA5 + DM. Variables were selected using univariable Cox regression and LASSO regression. Predictive models for mortality risks were constructed using machine learning‐based algorithms. A simplified scoring system was established based on the optimal model with thorough validation to ensure predictive accuracy.

Results

Seven variables emerged as key factors associated with mortality in MDA5 + DM and incorporated into the mortality risk prediction model: ferritin, lactate dehydrogenase, age at onset, CD8+ T‐cell count, C‐reactive protein, albumin, and lung computed tomography pattern of NSIP + OP. Among six models, the Cox proportional hazards model demonstrated superior discriminative ability and clinical utility and was translated into a simplified scoring system ‘FLATCAN’. This model achieved a concordance index of 0.815 and time‐dependent area under the receiver operating characteristic curves for predicting 3‐, 6‐, and 12‐month mortality of 0.895, 0.855, and 0.850, respectively. Patients were effectively stratified into low‐, intermediate‐, and high‐risk groups using the FLATCAN score. Further internal cross‐validation, time‐point splitting, and rapidly progressive interstitial lung disease‐based splitting confirmed the FLATCAN score's robust predictive ability.

Conclusion

The FLATCAN score provides an easy‐to‐use tool for predicting mortality risk in patients with MDA5 + DM and may facilitate improved risk stratification‐based patient management. image

Subjects

MeSH terms (MEDLINE)

DermatomyositisInterferon-Induced Helicase, IFIH1HumansMaleFemaleMiddle AgedRetrospective StudiesPrognosisRisk AssessmentAdultAgedTomography, X-Ray ComputedProportional Hazards ModelsC-Reactive Protein

Author keywords

anti‐melanoma differentiation‐associated gene 5 antibodiesdermatomyositisprognosisrisk prediction

Substances

Interferon-Induced Helicase, IFIH1IFIH1 protein, humanC-Reactive Protein

Authors and institutions

  • Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
  • Department of Rheumatology, Key Myositis Laboratories, China-Japan Friendship Hospital, Beijing, China.
  • Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

ORCID profiles: Chen Zong, Qinglin Peng

Funding

  • Elite Medical Professionals project of China-Japan Friendship Hospital
  • National High Level Hospital Clinical Research Funding
  • National Natural Science Foundation of China

Cite

APA

Zong, C., Wu, S., Zhu, L., Chen, Y., Zhang, X., Sun, C., Lu, X., Wang, G., & Peng, Q. (2025). The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis. Respirology, 30(12), 1153-1164. https://doi.org/10.1111/resp.70106

Vancouver

Zong C, Wu S, Zhu L, Chen Y, Zhang X, Sun C, et al. The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis. Respirology. 2025;30(12):1153-1164. doi:10.1111/resp.70106

BibTeX
@article{Zong2025,
  author = {Zong, Chen and Wu, Shiyu and Zhu, Longyang and Chen, Yiran and Zhang, Xinxin and Sun, Chao and Lu, Xin and Wang, Guochun and Peng, Qinglin},
  title = {The FLATCAN Model: A Novel Score for Predicting Mortality Risk in Anti‐Melanoma Differentiation‐Associated Gene 5‐Positive Dermatomyositis},
  journal = {Respirology},
  year = {2025},
  volume = {30},
  number = {12},
  pages = {1153--1164},
  doi = {10.1111/resp.70106}
}
Start for free →